MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    LRRK2 and GBA Founder Mutations and their Interactions in Parkinson’s Disease

    M. Kmiecik, G. Riboldi, R. Schneider, K. Stagaman, T. Filshtein Sonmez, A. Guan, M. Wetzel, P. Fontanillas, M. Holmes, S. Aslibekyan, L. Norcliffe-Kaufmann (Sunnyvale, USA)

    Objective: To evaluate the symptoms of Parkinson’s disease (PD) and time to diagnosis in single and dual carriers of LRRK2 G2019S and GBA N370S. Background:…
  • 2024 International Congress

    Unraveling the Role of Short Tandem Repeats in Parkinson’s disease, Essential tremor, and Amyotrophic lateral sclerosis: A Large Chinese Cohort Study

    Y. Zhao, Z. Liu, H. Pan, Q. Sun, J. Wang, J. Guo, B. Tang (Changsha, China)

    Objective: This study investigates the prevalence and impact of short tandem repeat (STR) mutations in the next-generation sequencing data of patients with Parkinson’s disease (PD), essential…
  • 2024 International Congress

    Investigating Copy Number Variations in SNCA and PRKN in a Cohort of Kazakhstani Patients with Parkinson’s Disease and Healthy Controls

    R. Kaiyrzhanov, N. Zharkynbekova, S. Abdraimova, C. Shashkin, Z. Myrzayev, A. Karimova, V. Akhmetzhanov, K. Mok, J. Hardy, H. Houlden (Shyment, Kazakhstan)

    Objective: To investigate the frequency of copy number variations (CNVs) in SNCA and PRKN in a cohort of Parkinson’s disease (PD) patients and healthy controls…
  • 2024 International Congress

    Screening for newly PD-associated RAB32 p.S71R variant in Latin America

    M. Rivera Paz, E. Waldo, T. Leal, P. Reyes-Pérez, M. Inca-Martinez, S. Alcauter, I. Amorín, M. Cornejo-Olivas, E. Dieguez, I. Estrada-Bellmann, A. Hernández-Medrano, M. Jimenez-Del-Rio, A. Lescano, B. Muñoz Ospina, K. Nuytemans, J. Orozco, V. Raggio, M. Rentería, J. Rios-Pinto, M. Rodriguez-Violante, K. Salinas Barboza, A. Schuh, C. Velez-Pardo, I. Mata (Cleveland, USA)

    Objective: Our aim was to identify whether a novel putative pathogenic variant in RAB32, a gene recently associated with familial forms of Parkinson’s Disease (PD),…
  • 2024 International Congress

    Basal ganglia theta oscillation as a predictor of levodopa-induced dyskinesias

    M. Wilken, L. Granda, I. Cruz Varela, M. Rossi, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

    Objective: To investigate the temporal and spatial relationship between local field potential (LFP) changes and dyskinesia development. Background: Levodopa-induced dyskinesias (LID) are an important burden…
  • 2024 International Congress

    Longitudinal Studies of LFP Activities During Acute and Chronic DBS Stimulation in PD Patients

    Y. Zhao, V. Rayudu, S. Santacruz, M. Varga (Austin, USA)

    Objective: This study investigates the changes in local field potential (LFP) during acute and chronic deep brain stimulation (DBS) in patients with Parkinson's disease (PD)…
  • 2024 International Congress

    Prokineticin-2 is highly expressed in colonic mucosa of early Parkinson’s disease patients

    G. Bellini, G. Palermo, F. Rettura, E. Del Prete, E. Unti, C. Ippolito, C. Pellegrini, D. Frosini, N. Bernardini, R. Ceravolo (Pisa, Italy)

    Objective: To investigate the expression of PK2 in colonic biopsies of PD patients. Background: Neuroinflammation is emerging as a key factor involved in the pathophysiology…
  • 2024 International Congress

    Genetic Variants and Levodopa Response in Parkinson’s Disease: Insights from MAO-B and DAT1 Polymorphisms

    S. Sarkar, A. Biswas, S. Ansari, S. Sengupta, S. Choudhury, R. Banerjee, S. Chatterjee, S. Dey, H. Kumar (Kolkata, India)

    Objective: This study aimed to find the association of genetic variations between Parkinson’s disease (PD) patients with and without levodopa-induced dyskinesia (LID). we intended to…
  • 2024 International Congress

    Association between Walking Pace, Brain Structure, and Risk of Parkinson’s Disease and Atypical Parkinsonism in the UK Biobank

    S. Wang, Y. Xiao, X. Zheng, J. Liu, J. Lin, T. Yang, Q. Jiang, C. Li, H. Shang (Chengdu, China)

    Objective: This study sought to explore the effects of walking pace on Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) investigating…
  • 2024 International Congress

    Evaluation of Neurotransmitter and Co-transmitter Expression in the Aging Human Locus Coeruleus: Relevance to Neurodegenerative Disorders.

    A. Bhattacharya, A. Mahadevan, R. Manjithaya, Y. Tc, P. Alladi (Bengaluru, India)

    Objective: To analyze the age-associated changes in the neurotransmitter/co-transmitter expression and morphometric profiles of human locus coeruleus (LC) neurons using autopsied human tissues. Background: LC…
  • « Previous Page
  • 1
  • …
  • 98
  • 99
  • 100
  • 101
  • 102
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley